BrainStorm Cell Therapeutics Inc. (BCLI) - Cash per Single Share

BrainStorm Cell Therapeutics Inc. - graphic logo of issuer BCLI

Brainstorm Cell (BCLI) focuses on developing cellular treatments for ALS, protecting its niche through patents. The cash per share trend confirms financial stability, with the 0.00 mark recording this metric. Business development remains independent of economic cycles, relying instead on FDA verdicts. High-tech bioreactors support this stability, operating on a strict calibration schedule to eliminate product defects.

BCLI Brainstorm Cell Therapeutics Inc.: Cash Funds per Share in the range 07/04/2022 - 08/02/2025

Comprehensive metric breakdowns and analytics for BrainStorm Cell Therapeutics (BCLI)

- cash availability and cash flow indicators:
Brand item of brainstorm-cell.com

Cash per share dynamics reflect the financial stability of Brainstorm Cell (BCLI) as a biotech issuer. This metric determines the volume of liquid assets attributable to a single security. The calculation is based on the ratio of total cash balance to the number of shares outstanding. For a company in the intensive R&D phase of NurOwn, this indicator demonstrates the funding autonomy of clinical protocols. A sufficient liquidity reserve minimizes the risks of expensive borrowing.

Analysis of competing companies

Biogen Corp (BIIB) - Cash Funds Calculated per Share|Cash per Share NBIX|RGC - Cash on Hand per Share|Cash Funds per Share Axsome Therapeutics AXSM|Cash per Share ACADIA Pharmaceuticals Inc. ACAD|xenon-pharma.com - Cash per Share|Cash on Hand per Share Viking Therapeutics|SUPN: Cash per Share|Catalyst Pharmaceuticals (CPRX) - Cash per Share|Cash per Single Share DNLI|Cash Funds per Single Share HRMY (Harmony Biosciences Holdings, Inc.)|Cash Funds per Share Biohaven Ltd. (BHVN)|Cash Calculated per Single Share AMLX|Cash Funds per Share trevitherapeutics.com TRVI|PRAX - Cash per Single Share|Anavex Life Sciences Corp - Cash per Share|Cash on Hand per Share CeriBell Corp|Prothena Corporation PLC (PRTA) - Cash Funds per Share|Alector Therapeutics - Amount of Cash per Share|Cash Funds per Share Annexon Biosciences|Cash on Hand per Share omeros.com OMER|Cash Funds per Share Neurogene (NGNE)|Cash Funds Calculated per Share AC Immune S.A.|Cash per Share VYGR (Voyager Therapeutics Inc)|Amount of Cash per Share NMRA|scilexholding.com - Cash per Share|TVGN (tevogen.com) - Cash Funds per Single Share|ACOG: Cash per Share|CGTX: Cash Calculated per Single Share|Cash Funds per Share Inhibikase Therapeutics|Cash Funds per Single Share SAVA (Cassava)|Cash Funds per Share Assertio Therapeutics (ASRT)|Coya Therapeutics - Cash Funds per Single Share|VistaGen Therapeutics, Inc. - Cash per Single Share|ovidrx.com (OVID) - Cash on Hand per Share|ABOS: Cash per Single Share|Cash on Hand per Share CervoMed Inc|alteritytherapeutics.com (ATHE) - Cash Funds per Share|Cash per Single Share Clene Nanomedicine|Cash per Single Share PEPG|Cash on Hand per Share Jupiter Neurosciences JUNS|Cash Funds per Share Relmada (RLMD)|Cash Funds Calculated per Share Annovis Bio, Inc.|Cash per Share GRCE (Grace Tx)|Firefly Neuroscience, Inc (AIFF) - Cash on Hand per Share|KLTO - Cash Funds per Share|Cash on Hand per Share NeuroSense Therapeutics Ltd|RVPH: Cash per Share|MetaVia, Inc. (MTVA) - Cash per Share|Cash Funds per Share NeurAxis|Cash per Share heliusmedical.com|Cash per Single Share PASG (Passage Bio Inc.)|Neuphoria Therapeutics - Cash Funds per Single Share|Minerva Neurosciences Corp - Cash per Single Share|Amount of Cash per Share ATHA|ADXN - Cash Funds per Share|Cash on Hand per Share Alzamend Neuro Inc.|Cyclerion Therapeutics (CYCN) - Cash Funds per Share|Cash Funds per Single Share PTIX|KTTA (pasitheaclinics.com) - Cash per Share|CRGT (cortigent.com) - Cash Calculated per Single Share|Cash per Share ATXI|CARA: Cash Money per Share|Chromocell Therapeutics Corp. - Cash per Single Share|Cash Funds Calculated per Share Eliem (ELYM)|ITCI: Cash per Single Share|Amount of Cash per Share LBPH (Longboard)|marinuspharma.com (MRNS) - Cash Funds per Share|NKGN - Cash Funds Calculated per Share|NRBO (neurobopharma.com) - Cash per Share|Sage Therapeutics (SAGE) - Cash Funds Calculated per Share|Cash per Single Share SNPX (Synaptogenix, Inc.)|TRVN - Cash on Hand per Share|Cash per Share VIGL (Vigil Neuro)|WENA: Cash Funds per Single Share|CERE - Cash Funds per Share